Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 7026 matches for

On November 20, 2017, the Typhoid Vaccine Acceleration Consortium (TyVAC) vaccinated the first of 20,000 children against typhoid, successfully launching a study to assess the impact of typhoid conjugate vaccines (TCVs) in preventing typhoid among children in Nepal.

Photo: Bill & Melinda Gates Foundation/Sam Reinders
Rinn Song

Rinn Song

Rinn Song - Clinical Scientist

Emma Francis

Emma Francis

Emma Francis - Research Practitioner

Amber Thompson

Amber Thompson

Amber Thompson - Senior QA and Sample Compliance Manager

Sarah Kelly

Sarah Kelly

MSc Sarah Kelly - Clinical Programme Director (Global)

Pratyasha Pal

Pratyasha Pal

Pratyasha Pal

Hannah Robinson

Hannah Robinson

Hannah Robinson - Clinical Operations Director

Sir Andrew Pollard

Sir Andrew Pollard

BSc MBBS PhD (Lond), DIC, MRCP (UK), FHEA, FRCPCH, MA, FMedSci, FRS Sir Andrew Pollard - Ashall Professor of Infection & Immunity

Roshni Mansfield

Roshni Mansfield

Yama G.Farooq

Yama G.Farooq

BCA Computer Application , MSc in Information Technology and Software Engineering Yama G.Farooq - Programming and Data Management Director

Rebecca Beckley

Rebecca Beckley

Rebecca Beckley - Project Manager

James Gilchrist

James Gilchrist

MBioch, MBBS, MRCPCH, DPhil, PGDip Paediatric Infectious Diseases James Gilchrist - Wellcome Career Development Fellow

Mercy Macharia

Mercy Macharia

Rachel Anslow

Rachel Anslow

Rachel Anslow - Senior Research Assistant

Kai Gao

Kai Gao

Seung Joon Kim

Seung Joon Kim

Pip Crowley

Pip Crowley

Philip Taylor

Philip Taylor

Manon Chatain

Manon Chatain

Manon Chatain - Clinical Research Practitioner

Jo Ning

Jo Ning - Research Assistant

Jesus Caro

Jesus Caro

Load More

Similar stories

Oxford vaccine against deadly Nipah virus granted EMA PRIME designation for the first time

The University of Oxford’s vaccine to protect people from deadly Nipah virus has been granted support from the PRIority MEdicines (PRIME) scheme offered by Europe’s medicines regulator, the European Medicines Agency (EMA). It is the first UK academic institution to be awarded this designation.

Professor Simon Draper elected Fellow of the Academy of Medical Sciences

New MenB Vaccine Shows Promise in Early-Stage Trial Results

Study identifies key immune structures in the gut that may drive coeliac disease

Study shows urgent change needed to reduce deaths from malaria and meningitis in comatose African children

Spotlight on Magdalen College Chapel for Rare Disease Day